Remove Generic Drugs Remove Medicine Remove Pharma Companies Remove Pharmacy
article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. Pharma companies have very little control over patients’ prices for their Rxs. A federal appeals court rejected Pfizer’s challenge to a U.S.

Pharmacy 226
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. Then there is the cost of generic drugs. bilĀ­lion in 2020 if it had purĀ­chased 77 of 89 drugs from Cuban’s firm.

Pharmacy 227
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cybersecurity in pharma: Securing the future

Pharmaceutical Technology

Earlier this year, Sun Pharmaceutical Industries , one of Indiaā€™s largest generic drug producers, reported a major cybersecurity breach , impacting its business operations. Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health.

article thumbnail

Pharmaā€™s climate change vulnerability and opportunity

pharmaphorum

Pharma companies are ā€œhighly vulnerableā€ to the effects of climate change, due to their reliance on global networks. In 2017, the global medicines supply was interrupted when Hurricane Maria hit Puerto Rico, home to more than 500 medical product facilities and producer of 10% of all drugs consumed in America.

article thumbnail

European Commission vs Big Pharma, or profit vs access? Ā 

Drug Discovery World

An example of the current disparity, drawn from data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), can be seen in Romania, Poland or Bulgaria, where a recently approved medicine will take more than 800 days on average before it becomes publicly available compared with Germany, where that figure is 133 days 3.

article thumbnail

Teva shares slide as it faces illegal kickback charges from US government

pharmaphorum

Teva mainly administered the scheme through its specialty pharmacy, Advanced Care Scripts (ACS) with payments amounting to around $300 million during the period, according to the complaint. The company will vigorously defend itself against these allegations.”

article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2. To many, the country is referred to as the ā€˜pharmacy of the worldā€™. So, what is driving this success, and will it continue?